2012. EGFR Tyrosine Kinase Inhibitors Prolong Overall Survival in EGFR Mutated Non-Small-Cell Lung Cancer Patients with Postsurgical Recurrence . Journal of Cancer Research Updates. 1, 1 (Jan. 2012),  102–107. DOI:https://doi.org/10.6000/1929-2279.2012.01.01.15.